Assertio Holdings, Inc.
US ˙ NasdaqCM ˙ US04546C2052

Introduction

This page provides a comprehensive analysis of the known insider trading history of David Matthew Stark. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate David Matthew Stark has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ASRT / Assertio Holdings, Inc. Director 107,500
US:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Exec. VP Chief Legal Officer 2,974
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by David Matthew Stark. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ASRT / Assertio Holdings, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ASRT / Assertio Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ASRT / Assertio Holdings, Inc. Insider Trades
Insider Sales ASRT / Assertio Holdings, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ASRT / Assertio Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ASRT / Assertio Holdings, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by David Matthew Stark as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-05-09 2025-05-07 4 ASRT Assertio Holdings, Inc.
Common Stock
A - Award 53,750 107,500 100.00
2024-11-12 2024-11-07 4 ASRT Assertio Holdings, Inc.
Common Stock
A - Award 53,750 53,750
2023-03-08 2023-03-07 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -49,475 2,974 -94.33 9.43 -466,445 28,042
2023-03-08 2023-03-06 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -16,491 52,449 -23.92 9.93 -163,770 520,870
2023-03-07 2023-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 20,199 68,940 41.44
2023-03-07 2023-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 31,836 48,741 188.32
2023-03-07 2023-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 13,931 16,905 468.36
2023-03-02 2023-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -44,953 2,974 -93.79 9.89 -444,432 29,407
2023-03-02 2023-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 44,953 47,927 1,511.34
2023-03-02 2023-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -18,430 2,974 -86.10 9.89 -182,210 29,407
2023-03-02 2023-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 18,430 21,404 619.62
2022-07-29 2022-07-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -58,163 2,974 -95.13 9.04 -525,590 26,878
2022-03-08 2022-03-07 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -9,057 61,137 -12.90 7.37 -66,720 450,381
2022-03-08 2022-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -20,199 60,599 -25.00
2022-03-08 2022-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 20,199 70,194 40.40
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 127,345 127,345
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -13,930 13,931 -50.00
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -37,939 0 -100.00
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -6,246 49,995 -11.11 7.48 -46,736 374,091
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 13,930 56,241 32.92
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -17,008 42,311 -28.67 7.48 -127,262 316,595
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 37,939 59,319 177.45
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -18,430 36,860 -33.33
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -6,452 21,380 -23.18 8.14 -52,533 174,083
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 18,430 27,832 196.01
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -12,538 0 -100.00
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -6,110 9,402 -39.39 9.06 -55,358 85,188
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 12,538 15,512 421.53
2022-02-10 2022-02-08 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 37,939 37,939
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -37,884 0 -100.00
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -37,884 2,974 -92.72 10.22 -387,125 30,394
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 37,884 40,858 1,273.67
2021-03-08 2021-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 80,798 80,798
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -13,930 27,861 -33.33
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -13,930 2,974 -82.40 10.57 -147,186 31,428
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 13,930 16,904 468.33
2021-03-02 2021-03-01 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -18,430 2,974 -86.10 10.83 -199,612 32,215
2021-03-02 2021-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -18,430 55,290 -25.00
2021-03-02 2021-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 18,430 21,404 619.62
2021-02-17 2021-02-16 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -3,926 2,974 -56.90 11.12 -43,669 33,084
2021-02-17 2021-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -3,926 0 -100.00
2021-02-17 2021-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 3,926 6,900 131.99
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 37,884 37,884
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -12,538 12,538 -50.00
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -52,774 2,974 -94.66 12.69 -669,940 37,758
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -12,538 55,748 -18.36 12.69 -159,164 707,698
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
A - Award 52,774 68,286 340.21
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 12,538 15,512 421.53
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -2,359 0 -100.00
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -2,359 2,974 -44.23 7.16 -16,899 21,307
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 2,359 5,333 79.31
2020-03-03 2020-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 73,720 73,720
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -3,926 3,926 -50.00
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -13,090 0 -100.00
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -3,926 2,974 -56.90 12.14 -47,670 36,116
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -13,090 6,900 -65.48 12.14 -158,941 83,786
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 3,926 19,990 24.44
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 13,090 16,064 440.09
2020-02-13 2020-02-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 13,090 13,090
2020-02-11 2020-02-10 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -12,538 2,974 -80.83 12.24 -153,471 36,408
2020-02-11 2020-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -12,538 25,076 -33.33
2020-02-11 2020-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 12,538 15,512 421.53
2019-03-19 2019-03-18 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -2,358 2,974 -44.22 16.43 -38,742 48,869
2019-03-19 2019-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -2,358 2,359 -49.99
2019-03-19 2019-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 2,358 5,332 79.28
2019-03-14 2019-03-12 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -2,444 0 -100.00
2019-03-14 2019-03-12 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -2,444 2,974 -45.11 15.82 -38,664 47,055
2019-03-14 2019-03-12 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 2,444 5,418 82.17
2019-03-06 2019-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 41,791 41,791
2019-02-19 2019-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -3,926 7,852 -33.33
2019-02-19 2019-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -3,926 2,974 -56.90 17.74 -69,647 52,766
2019-02-19 2019-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 3,926 6,900 131.99
2018-03-20 2018-03-19 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -2,358 2,974 -44.22 18.38 -43,340 54,669
2018-03-20 2018-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -2,358 4,717 -33.33
2018-03-20 2018-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 2,358 5,332 79.28
2018-03-14 2018-03-12 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -2,441 2,444 -49.97
2018-03-14 2018-03-12 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -2,441 2,974 -45.08 19.20 -46,867 57,108
2018-03-14 2018-03-12 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 2,441 5,415 82.07
2018-02-12 2018-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 37,614 37,614
2018-02-12 2018-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Stock Options (right to buy)
A - Award 95,890 95,890
2018-01-02 3 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
5,949
2018-01-02 3 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
5,949
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)